Validation of diagnostic artificial intelligence models for prostate pathology in a Middle Eastern cohort

Artificial intelligence (AI) for pathology is accelerating cancer diagnostics. For global adoption, studies in currently under-represented populations - where the potential gains from AI may also be greatest - are needed. We present the first external validation study in a Middle Eastern setting, focusing on diagnosis and Gleason grading of prostate cancer. We digitised 339 prostate glass slides from Kurdistan, Iraq, representing a consecutive series of 185 patients from 2013 to 2024. Each slide was scanned on three digital pathology scanners, generating 1,017 whole-slide images. Task-specific and foundation AI models demonstrated AI-pathologist grading concordance similar to pathologist-pathologist concordance (Cohen's quadratically weighted kappa 0.801 vs. 0.799). Cross-scanner concordance was high (kappa > 0.90) for all AI models across three scanners. The demonstrated robust performance on a low-cost compact scanner could enable validation studies in non-digitalised settings and cost-effective AI adoption in laboratories with limited sample volumes. The publicly shared dataset supports further research to facilitate broader adoption of AI pathology.

Authors

Institutions

Publication Details

Journal
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
Published
2026-10-10
DOI
https://doi.org/10.1007/s00428-026-04742-5
Citations
1
Primary Topic
AI in cancer detection
Type
article
Field-Weighted Citation Impact
3.67

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Validation of diagnostic artificial intelligence models for prostate pathology in a Middle Eastern cohort

Abdulbasit K. Faeq Al-Talabani, Nita Mulliqi, Abdulbasit K. Al‐Talabani, Han N. Mohammed Fadhl et al.
1 citations
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
AI in cancer detection
3.67
article

Validation of diagnostic artificial intelligence models for prostate pathology in a Middle Eastern cohort

Abdulbasit K. Faeq Al-Talabani, Nita Mulliqi, Abdulbasit K. Al‐Talabani, Han N. Mohammed Fadhl, Kimmo Kartasalo, Kelvin Szolnoky, Anders Blilie, Julia Anna Mielcarz, Peshawa J. Muhammad Ali, Saman S. Abdulla, Xiaoyi Ji, Navin Vincent
article en
1 citations

Abstract

Artificial intelligence (AI) for pathology is accelerating cancer diagnostics. For global adoption, studies in currently under-represented populations - where the potential gains from AI may also be greatest - are needed. We present the first external validation study in a Middle Eastern setting, focusing on diagnosis and Gleason grading of prostate cancer. We digitised 339 prostate glass slides from Kurdistan, Iraq, representing a consecutive series of 185 patients from 2013 to 2024. Each slide was scanned on three digital pathology scanners, generating 1,017 whole-slide images. Task-specific and foundation AI models demonstrated AI-pathologist grading concordance similar to pathologist-pathologist concordance (Cohen's quadratically weighted kappa 0.801 vs. 0.799). Cross-scanner concordance was high (kappa > 0.90) for all AI models across three scanners. The demonstrated robust performance on a low-cost compact scanner could enable validation studies in non-digitalised settings and cost-effective AI adoption in laboratories with limited sample volumes. The publicly shared dataset supports further research to facilitate broader adoption of AI pathology.

Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
University of Turku (FI), Hawler Medical University (IQ), Stavanger University Hospital (NO), Science for Life Laboratory (SE), Karolinska Institutet (SE), University of Kurdistan Hewler (IQ), Koya University (IQ), University of Sulaimani (IQ), University of Stavanger (NO)
Cancerfonden, Karolinska Institutet, Knut och Alice Wallenbergs Stiftelse, Vetenskapsrådet, Instrumentariumin Tiedesäätiö, Science for Life Laboratory, National Supercomputer Centre, Linköpings Universitet
Good health and well-being
Openalex Percentile: Top 11%
AI in cancer detection
3.67
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.